Market Place
Sourcing Support
Boehringer Taps Pharma Veteran; BlueRock CSO Departs
01 May 2026 //
ENDPOINTS
NIPER Hajipur Signs MoU with Boehringer Ingelheim India
25 Apr 2026 //
INDPHARMAPOST
Boehringer, Amgen Scrap Immunology Assets, Citing Low Potential
14 Apr 2026 //
FIERCE BIOTECH
Novo`s GLP-1 Pioneer Retires; Obesity Leader Joins Boehringer
10 Apr 2026 //
ENDPOINTS NEWS
Click Therapeutics, Boehringer Ingelheim Secure Series D
09 Apr 2026 //
GLOBENEWSWIRE
Boehringer Ingelheim Boosts Ecuador`s Rabies-Free Effort
09 Apr 2026 //
GLOBENEWSWIRE
Cue Bio to Receive $7.5M Milestone From Boehringer
08 Apr 2026 //
GLOBENEWSWIRE
ADCs, TCEs Among `Exciting Things` On Boehringer`s Shopping List
03 Apr 2026 //
FIERCE BIOTECH
Boehringer Ingelheim`s Sales Grow 7.3% via Two 2025 Launches
25 Mar 2026 //
GLOBENEWSWIRE
Boehringer touts promising launches of Hernexeos, Jascayd
25 Mar 2026 //
FIERCE PHARMA
Zomedica, Boehringer Expand Equine Endocrine Testing via TRUFORMA
18 Mar 2026 //
PHARMIWEB
Rising Stars: Chris Kraemer On The Power Of Patient Impact
04 Mar 2026 //
FIERCE PHARMA
Boehringer Ingelheim Ends OSE Partnership Due To Mid-Stage Data
03 Mar 2026 //
BIOSPACE
OSE Refocuses on Late-Stage Lusvertikimab, Tedopi
02 Mar 2026 //
GLOBENEWSWIRE
Boehringer Ingelheim India Names Meenal Gauri Managing Director
25 Feb 2026 //
INDPHARMAPOST
Boehringer Ingelheim Gets EUA For IVOMEC 1% Injection
06 Feb 2026 //
PR NEWSWIRE
IQVIA Boehringer Ingelheim Partner For Global Commercial Data
29 Jan 2026 //
BUSINESSWIRE
Boehringer in Deal with China`s Simcere to License IBD Drug
28 Jan 2026 //
REUTERS
Boehringer Ingelheim, Viyash Scientific Sign Pet Healthcare Pact
23 Jan 2026 //
ECONOMICTIMES
FDA Approves First Dog Heart Failure Onset Delay Drug
20 Jan 2026 //
PR NEWSWIRE
FDA Delays Decision On Lilly`s Obesity Drug Orforglipron
17 Jan 2026 //
REUTERS
Tempus Achieves Record Total Contract Value Exceeding $1.1 B
11 Jan 2026 //
BUSINESSWIRE
Boehringer Continues Kidney Dealmaking With $120M Variant Pact
06 Jan 2026 //
FIERCE BIOTECH
Boehringer Ingelheim Signs U.S. Deal to Cut Drug Costs
20 Dec 2025 //
PR NEWSWIRE
Boehringer Ingelheim Appoints New Board Member
28 Nov 2025 //
GLOBENEWSWIRE
Boehringer Ingelheim Secures EU CVMP Nod For Avian Influenza
20 Nov 2025 //
GLOBENEWSWIRE
Boehringer Ingelheim, CDR-Life Collaborate On CDR111
04 Nov 2025 //
BUSINESSWIRE
Jascayd Approved in China for The Treatment of IPF
22 Oct 2025 //
GLOBENEWSWIRE
How Boehringer Ingelheim Is Buttressing Its US Business
10 Oct 2025 //
FIERCE PHARMA
Boehringer Acquires Oncology Program From Accent Therapeutics
08 Oct 2025 //
PR NEWSWIRE
Novartis, Boehringer Debut DTC Programs With Reduced Drug Prices
29 Sep 2025 //
FIERCE PHARMA
Boehringer Ingelheim Launches DTC Platform For Treatment Access
29 Sep 2025 //
GLOBENEWSWIRE
Palatin Gets €5.5M Milestone In Retinal Deal With Boehringer
22 Sep 2025 //
PR NEWSWIRE
Onco360® Chosen as Specialty Pharmacy Partner for HERNEXEOS®
20 Aug 2025 //
GLOBENEWSWIRE
Boehringer Honors Young Researchers at 2025 Symposium
11 Aug 2025 //
PR NEWSWIRE
Boehringer Links with Start-Up Re-Vana in $1B+ Eye Deal
29 Jul 2025 //
BIOSPACE
Solid Growth & Investments Set Stage for 2 Key Launch in H2 2025
24 Jul 2025 //
GLOBENEWSWIRE
Foundation & Boehringer Launch Lung Cancer Research Project
17 Jun 2025 //
PR NEWSWIRE
Echosens & Boehringer Ingelheim Expand Collaboration
10 Jun 2025 //
CONTRACTPHARMA
Boehringer Ingelheim`s Vision for Cancer Care at ASCO 2025
22 May 2025 //
PR NEWSWIRE
BioMed X Institute, Boehringer Call for Research Proposal
22 May 2025 //
CONTRACTPHARMA
Tempus Collaborates with Boehringer Ingelheim on Cancer Pipeline
14 May 2025 //
BUSINESSWIRE
Boehringer begins Phase II study for Geographic Atrophy
07 May 2025 //
GLOBENEWSWIRE
Life Sciences Leaders Unify at Veeva Commercial Summit
06 May 2025 //
PR NEWSWIRE
Datavant, Boehringer Expand Partnership for Real-World Evidence
05 May 2025 //
BUSINESSWIRE
Oxford, Boehringer Ingelheim, Cumulus Neuroscience launch study
29 Apr 2025 //
GLOBENEWSWIRE
Boehringer`s zongertinib data show durable results in HER2 NSCLC
28 Apr 2025 //
GLOBENEWSWIRE
Boehringer Ingelheim announces succession in Chairmen and Board
17 Apr 2025 //
GLOBENEWSWIRE
Amid US uncertainty, Boehringer projects `slight` sales increase
02 Apr 2025 //
FIERCE PHARMA
Boehringer Ingelheim reaches more Patients in 2024, plans launches
02 Apr 2025 //
GLOBENEWSWIRE
Cognizant and Boehringer Ingelheim Launch One Medicine Platform
11 Mar 2025 //
CONTRACTPHARMA
Spevigo Data In GPP Patient Outcomes Presented At AAD 2025
07 Mar 2025 //
PR NEWSWIRE
Boehringer wins jury verdict in Zantac retrial in Illinois
26 Feb 2025 //
ENDPTS
CDR-Life Hits Fifth Milestone With Boehringer In Geographic Atrophy
25 Feb 2025 //
BUSINESSWIRE
Boehringer Ingelheim Welcomes Brian As US Pharma President
20 Feb 2025 //
PR NEWSWIRE
Boehringer’s Zongertinib Gets FDA Priority Review For HER2 NSCLC
19 Feb 2025 //
GLOBENEWSWIRE
FDA Grants Review To Boehringer’s Zongertinib For HER2-Mutant NSCLC
19 Feb 2025 //
PR NEWSWIRE
Boehringer widens fibrosis drug`s potential after 2nd ph. 3 win
11 Feb 2025 //
PRESS RELEASE
Boehringer Updates Ph 3 Program For Iclepertin In Schizophrenia
16 Jan 2025 //
GLOBENEWSWIRE
Malaysia Approves Spesolimab for Generalised Pustular Psoriasis
13 Dec 2024 //
BIOSPECTRUM
